aim

  1. Sly Saint

    Ampligen in Phase 2 Clinical Study for the Treatment of Post-COVID Conditions

    Several posts have been moved from this thread: Ampligen - Hemispherx Biopharma re ME/CFS not relating to ME but Covid-19 AIM ImmunoTech inks deal to research vaping device as a vehicle for Ampligen to treat coronavirus...
    • Sly Saint
    • Thread
    • aim ampligen double-blind phase ii randomized controlled trial rintatolimod
    • Replies: 36
    • Forum: Long Covid research
  2. Sly Saint

    Ampligen for ME/CFS

    "PHILADELPHIA, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE American:HEB) announced today its financial results for the third quarter ended September 30, 2017." "We have secured our first country approval for Ampligen® in ME/CFS and we expect several more in the coming years."...
Back
Top Bottom